FDA

Latest News

FDA Advisory Committee Supports Donanemab in Alzheimer’s Disease
FDA Advisory Committee Supports Donanemab in Alzheimer’s Disease

June 11th 2024

Committee members, however, also said more data are needed on donanemab to treat patients in underrepresented patient groups, including Latin American and African American patients and special populations such as Down syndrome.

steph photographies-stock.adobe.com
FDA Sets Review Date for Tagrisso for Specific Lung Cancer Mutations

June 10th 2024

Dr_Microbe-stock.adobe.com
FDA Assigns Goal Date for Maintenance Dosing of Leqembi

June 10th 2024

 Stepan Popov-stock.adobe.com
Updated: FDA Committee, Concerned about Bias, Votes No on Psychedelic in PTSD

June 5th 2024

photoopus-stock.adobe.com
FDA Approves Moderna’s RSV Vaccine

June 3rd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.